Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KSE - Delayed Quote KRW

Dentium CO., LTD (145720.KS)

Compare
76,600.00
+600.00
+(0.79%)
At close: 3:30:15 PM GMT+9
Loading Chart for 145720.KS
  • Previous Close 76,000.00
  • Open 73,500.00
  • Bid 76,300.00 x --
  • Ask 76,400.00 x --
  • Day's Range 73,500.00 - 77,900.00
  • 52 Week Range 54,000.00 - 140,400.00
  • Volume 87,023
  • Avg. Volume 57,319
  • Market Cap (intraday) 660.59B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 400.00 (0.34%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est 101,000.00

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

www.dentium.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 145720.KS

View More

Performance Overview: 145720.KS

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

145720.KS
23.15%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

145720.KS
41.49%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

145720.KS
6.32%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

145720.KS
144.57%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 145720.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 145720.KS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    655.42B

  • Enterprise Value

    802.32B

  • Trailing P/E

    9.01

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.61

  • Price/Book (mrq)

    1.18

  • Enterprise Value/Revenue

    1.97

  • Enterprise Value/EBITDA

    6.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.32%

  • Return on Assets (ttm)

    11.00%

  • Return on Equity (ttm)

    21.68%

  • Revenue (ttm)

    407.11B

  • Net Income Avi to Common (ttm)

    94.92B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    88.72B

  • Total Debt/Equity (mrq)

    46.04%

  • Levered Free Cash Flow (ttm)

    25.36B

Research Analysis: 145720.KS

View More

Company Insights: 145720.KS

Research Reports: 145720.KS

View More

People Also Watch